Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HeartBeam, Inc. stock logo
BEAT
HeartBeam
$0.39
-10.3%
$0.49
$0.39
$4.00
$24.44M-0.8347,042 shs597,549 shs
Femasys Inc. stock logo
FEMY
Femasys
$2.58
+0.8%
$2.86
$2.02
$22.20
$21.44M-2.07104,539 shs34,100 shs
Lifeward Ltd. stock logo
LFWD
Lifeward
$7.08
+1.9%
$7.30
$4.14
$10.56
$19.65M0.394,257 shs6,415 shs
Sonendo, Inc. stock logo
SONX
Sonendo
$1.89
+11.2%
$1.02
$0.02
$1.89
$9.03M1.811,300 shs385 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HeartBeam, Inc. stock logo
BEAT
HeartBeam
-10.33%-5.01%-19.52%-39.23%-76.14%
Femasys Inc. stock logo
FEMY
Femasys
+0.78%+1.57%-13.42%-28.33%-62.54%
Lifeward Ltd. stock logo
LFWD
Lifeward
+0.01%+2.39%-2.95%+2.83%-13.74%
Sonendo, Inc. stock logo
SONX
Sonendo
+11.18%+45.38%+225.86%+215.00%+656.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HeartBeam, Inc. stock logo
BEAT
HeartBeam
$0.39
-10.3%
$0.49
$0.39
$4.00
$24.44M-0.8347,042 shs597,549 shs
Femasys Inc. stock logo
FEMY
Femasys
$2.58
+0.8%
$2.86
$2.02
$22.20
$21.44M-2.07104,539 shs34,100 shs
Lifeward Ltd. stock logo
LFWD
Lifeward
$7.08
+1.9%
$7.30
$4.14
$10.56
$19.65M0.394,257 shs6,415 shs
Sonendo, Inc. stock logo
SONX
Sonendo
$1.89
+11.2%
$1.02
$0.02
$1.89
$9.03M1.811,300 shs385 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HeartBeam, Inc. stock logo
BEAT
HeartBeam
-10.33%-5.01%-19.52%-39.23%-76.14%
Femasys Inc. stock logo
FEMY
Femasys
+0.78%+1.57%-13.42%-28.33%-62.54%
Lifeward Ltd. stock logo
LFWD
Lifeward
+0.01%+2.39%-2.95%+2.83%-13.74%
Sonendo, Inc. stock logo
SONX
Sonendo
+11.18%+45.38%+225.86%+215.00%+656.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HeartBeam, Inc. stock logo
BEAT
HeartBeam
2.56
Moderate Buy$4.00928.54% Upside
Femasys Inc. stock logo
FEMY
Femasys
2.50
Moderate Buy$50.001,837.98% Upside
Lifeward Ltd. stock logo
LFWD
Lifeward
2.25
Hold$10.0041.34% Upside
Sonendo, Inc. stock logo
SONX
Sonendo
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SONX, BEAT, FEMY, and LFWD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/22/2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
DowngradeBuyNeutral
9/2/2026
Lifeward Ltd. stock logo
LFWD
Lifeward
UpgradeSell (E+)Sell (D-)
8/21/2026
Lifeward Ltd. stock logo
LFWD
Lifeward
Reiterated RatingBuy
8/21/2026
Lifeward Ltd. stock logo
LFWD
Lifeward
Reiterated RatingBuy$10.00
8/18/2026
Lifeward Ltd. stock logo
LFWD
Lifeward
DowngradeSell (D-)Sell (E+)
8/18/2026
Femasys Inc. stock logo
FEMY
Femasys
Lower Price TargetBuy$10.00
8/17/2026
Femasys Inc. stock logo
FEMY
Femasys
DowngradeSell (D-)Sell (E+)
8/14/2026
Femasys Inc. stock logo
FEMY
Femasys
Lower Price TargetBuy$10.00
8/3/2026
Lifeward Ltd. stock logo
LFWD
Lifeward
UpgradeSell (E+)Sell (D-)
7/31/2026
Femasys Inc. stock logo
FEMY
Femasys
UpgradeSell (E+)Sell (D-)
7/27/2026
Lifeward Ltd. stock logo
LFWD
Lifeward
UpgradeStrong SellHold
(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HeartBeam, Inc. stock logo
BEAT
HeartBeam
N/AN/AN/AN/A$0.06 per shareN/A
Femasys Inc. stock logo
FEMY
Femasys
$2.29M9.44N/AN/A$2.01 per share1.28
Lifeward Ltd. stock logo
LFWD
Lifeward
$22.03M0.91N/AN/A$5.52 per share1.28
Sonendo, Inc. stock logo
SONX
Sonendo
$44.40M0.20N/AN/A$89.42 per share0.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HeartBeam, Inc. stock logo
BEAT
HeartBeam
-$21.01M-$0.51N/AN/AN/AN/A-686.78%-348.65%11/12/2026 (Estimated)
Femasys Inc. stock logo
FEMY
Femasys
-$18.63M-$3.53N/AN/AN/A-534.36%-225.97%-74.68%11/17/2026 (Estimated)
Lifeward Ltd. stock logo
LFWD
Lifeward
-$19.91M-$16.82N/AN/AN/A-141.28%-235.86%-81.72%11/13/2026 (Estimated)
Sonendo, Inc. stock logo
SONX
Sonendo
-$60.92M-$71.12N/AN/AN/A-92.74%-184.01%-68.60%11/11/2026 (Estimated)

Latest SONX, BEAT, FEMY, and LFWD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/15/2026Q2 2026
Lifeward Ltd. stock logo
LFWD
Lifeward
-$1.39-$1.46-$0.07-$4.12$6.53 million$6.62 million
8/14/2026Q2 2026
Femasys Inc. stock logo
FEMY
Femasys
-$1.31-$1.33-$0.02-$1.33$0.73 million$0.33 million
8/13/2026Q2 2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
-$0.0860-$0.10-$0.0140-$0.10$0.15 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
HeartBeam, Inc. stock logo
BEAT
HeartBeam
N/AN/AN/AN/AN/A
Femasys Inc. stock logo
FEMY
Femasys
N/AN/AN/AN/AN/A
Lifeward Ltd. stock logo
LFWD
Lifeward
N/AN/AN/AN/AN/A
Sonendo, Inc. stock logo
SONX
Sonendo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HeartBeam, Inc. stock logo
BEAT
HeartBeam
N/A
3.66
3.61
Femasys Inc. stock logo
FEMY
Femasys
0.89
2.14
0.55
Lifeward Ltd. stock logo
LFWD
Lifeward
0.70
2.33
1.77
Sonendo, Inc. stock logo
SONX
Sonendo
0.55
1.82
1.22

Institutional Ownership

CompanyInstitutional Ownership
HeartBeam, Inc. stock logo
BEAT
HeartBeam
7.77%
Femasys Inc. stock logo
FEMY
Femasys
65.27%
Lifeward Ltd. stock logo
LFWD
Lifeward
26.76%
Sonendo, Inc. stock logo
SONX
Sonendo
28.68%

Insider Ownership

CompanyInsider Ownership
HeartBeam, Inc. stock logo
BEAT
HeartBeam
17.95%
Femasys Inc. stock logo
FEMY
Femasys
7.75%
Lifeward Ltd. stock logo
LFWD
Lifeward
1.50%
Sonendo, Inc. stock logo
SONX
Sonendo
7.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
HeartBeam, Inc. stock logo
BEAT
HeartBeam
1,70056.35 million46.23 millionNot Optionable
Femasys Inc. stock logo
FEMY
Femasys
548.38 million7.73 millionNot Optionable
Lifeward Ltd. stock logo
LFWD
Lifeward
812.83 million2.79 millionOptionable
Sonendo, Inc. stock logo
SONX
Sonendo
2504.78 million393,000Not Optionable

Recent News About These Companies

Sonendo names John McGaugh COO
Sonendo Inc.
Sonendo, Inc. (SONX) Q2 2024 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
HeartBeam stock logo

HeartBeam NASDAQ:BEAT

$0.39 -0.04 (-10.33%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$0.40 +0.01 (+3.63%)
As of 06:40 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.

Femasys stock logo

Femasys NASDAQ:FEMY

$2.58 +0.02 (+0.78%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$2.55 -0.03 (-1.16%)
As of 05:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Lifeward stock logo

Lifeward NASDAQ:LFWD

$7.08 +0.14 (+1.95%)
Closing price 09/23/2026 03:58 PM Eastern
Extended Trading
$7.08 0.00 (0.00%)
As of 09/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Sonendo stock logo

Sonendo NYSE:SONX

$1.89 +0.19 (+11.18%)
As of 09/23/2026 02:09 PM Eastern

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.